Immune Response to Posterior Spinal Fusion in Scoliosis
This study is looking at how your body's immune system reacts to posterior spinal fusion (PSF) surgery for scoliosis. Researchers want to see if patients with neuromuscular scoliosis have a stronger immune response compared to those with idiopathic scoliosis after this surgery. They will do this by taking blood samples before and after surgery to measure immune system markers. The study aims to understand if a stronger immune response in neuromuscular scoliosis might explain why these patients sometimes need more fluid during recovery. You can join if you are having PSF for either idiopathic or neuromuscular scoliosis, are between 0 and 99 years old, and are not taking certain immune-affecting medications or chronic steroids. The study status is currently unclear.
- Study design
- This is an observational study involving 20 participants, 10 with idiopathic scoliosis and 10 with neuromuscular scoliosis. It is not a randomized study and does not involve new medications or devices.
- What's involved
- You would have two blood samples taken: one before surgery and one after surgery (either in the recovery room or intensive care unit). These samples are taken during routine procedures.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your immune response will be measured from enrollment until approximately one hour after surgery completion.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Ambrish Patel, MD · PRINCIPAL_INVESTIGATOR · Nationwide Children's Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Immune response to posterior spinal fusion in patients with neuromuscular scoliosis compared to patients with idiopathic scoliosisFrom enrollment to approximately one hour after surgery completion.
Blood samples to determine serum immunophenotyping using cytokine profiles for immune response testing.